Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 | P03952 | 3/20 | 0.51 |
| ▸ | CA1 | P00915 | 5/20 | 0.47 |
| ▸ | CA2 | P00918 | 5/20 | 0.47 |
| ▸ | CA9 | Q16790 | 5/20 | 0.47 |
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | TNKS | O95271 | 1/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.45 |
| ▸ | KLK1 | P06870 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18360525 | 0.86 | TNKS (0.46) | KLKB1CA1CA2CA9CA12 | |
| SCHEMBL18360446 | 0.86 | TNKS (0.46) | KLKB1CA1CA2CA9CA12 | |
| SCHEMBL30616868 | 0.81 | CA1 (0.67) | CA1CA2CA9CA12CA4 | |
| SCHEMBL18360541 | 0.81 | CA1 (0.67) | CA1CA2CA9CA12CA4 | |
| SCHEMBL30616853 | 0.81 | CA1 (0.59) | CA1CA2CA9CA12CA4 | |
| SCHEMBL16863676 | 0.79 | CA1 (0.55) | CA1CA2CA9CA12CA4 | |
| SCHEMBL18360455 | 0.78 | CYP1A2 (0.57) | CA1CA2CA9CA12CA4 | |
| SCHEMBL18360416 | 0.77 | NPC1 (0.52) | CA1CA2CA9CA12CA4 | |
| SCHEMBL30616863 | 0.77 | CA12 (0.57) | CA1CA2CA9CA12CA4 | |
| SCHEMBL18360510 | 0.76 | EPHX2 (0.53) | CA1CA2CA9CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | SYNGENTA PARTICIPATIONS AG (SE) | 2017-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | CYP4X1, BROX, CYP1B1 | KLKB1 3565/4885CA1 3964/4885CA2 1649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.